See more : Vinda International Holdings Limited (3331.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Alfresa Holdings Corporation (ARHCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alfresa Holdings Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Zhejiang United Investment Holdings Group Limited (8366.HK) Income Statement Analysis – Financial Results
- SGS SA (SGSOY) Income Statement Analysis – Financial Results
- MLP Group S.A. (MLG.WA) Income Statement Analysis – Financial Results
- Pharma Mar, S.A. (0RC6.L) Income Statement Analysis – Financial Results
- Zhejiang Youpon Integrated Ceiling Co.,Ltd. (002718.SZ) Income Statement Analysis – Financial Results
Alfresa Holdings Corporation (ARHCF)
About Alfresa Holdings Corporation
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,858.50B | 2,696.07B | 2,585.64B | 2,603.26B | 2,698.56B | 2,640.53B | 2,602.93B | 2,551.92B | 2,576.36B | 2,421.11B | 2,504.57B | 2,387.44B | 2,333.47B | 2,183.36B | 2,059.33B | 1,934.89B | 1,769.38B | 1,589.88B | 1,411.69B |
| Cost of Revenue | 2,652.13B | 2,503.98B | 2,398.17B | 2,427.73B | 2,491.43B | 2,439.22B | 2,409.37B | 2,369.35B | 2,379.17B | 2,255.35B | 2,333.03B | 2,228.08B | 2,189.43B | 2,040.24B | 1,915.83B | 1,796.00B | 1,622.21B | 1,455.20B | 1,296.44B |
| Gross Profit | 206.37B | 192.09B | 187.47B | 175.54B | 207.12B | 201.31B | 193.56B | 182.57B | 197.19B | 165.76B | 171.54B | 159.36B | 144.03B | 143.12B | 143.50B | 138.90B | 147.17B | 134.69B | 115.25B |
| Gross Profit Ratio | 7.22% | 7.12% | 7.25% | 6.74% | 7.68% | 7.62% | 7.44% | 7.15% | 7.65% | 6.85% | 6.85% | 6.67% | 6.17% | 6.55% | 6.97% | 7.18% | 8.32% | 8.47% | 8.16% |
| Research & Development | 0.00 | 2.09B | 1.37B | 1.44B | 1.40B | 1.25B | 1.16B | 1.14B | 1.12B | 1.07B | 1.09B | 1.24B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 135.49B | 126.01B | 124.52B | 123.85B | 130.18B | 129.78B | 125.49B | 123.72B | 126.42B | 113.99B | 113.59B | 112.50B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 22.41B | 26.11B | 24.70B | 22.90B | 21.42B | 19.94B | 18.46B | 17.75B | 17.15B | 15.90B | 15.82B | 15.93B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 155.70B | 152.11B | 149.22B | 146.75B | 151.60B | 149.73B | 143.96B | 141.47B | 143.57B | 129.90B | 129.41B | 128.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 12.22B | 1.06B | 1.27B | 8.96B | 8.19B | 7.77B | 7.64B | 7.94B | 7.92B | 7.54B | 8.16B | 7.56B | 8.92B | 8.50B | 7.63B | 6.96B | 6.50B | 5.45B | 4.51B |
| Operating Expenses | 167.91B | 161.94B | 158.38B | 154.86B | 159.48B | 156.54B | 151.80B | 149.34B | 151.91B | 136.53B | 136.58B | 135.81B | 134.65B | 133.80B | 128.84B | 130.11B | 121.82B | 112.70B | 100.40B |
| Cost & Expenses | 2,820.04B | 2,665.92B | 2,556.55B | 2,582.59B | 2,650.91B | 2,595.76B | 2,561.17B | 2,518.69B | 2,531.07B | 2,391.88B | 2,469.61B | 2,363.89B | 2,324.09B | 2,174.04B | 2,044.67B | 1,926.11B | 1,744.03B | 1,567.89B | 1,396.84B |
| Interest Income | 59.00M | 56.00M | 64.00M | 67.00M | 104.00M | 104.00M | 102.00M | 116.00M | 205.00M | 216.00M | 194.00M | 194.00M | 186.00M | 257.00M | 282.00M | 349.00M | 277.00M | 180.00M | 113.00M |
| Interest Expense | 132.00M | 64.00M | 73.00M | 85.00M | 98.00M | 93.00M | 94.00M | 104.00M | 121.00M | 122.00M | 142.00M | 157.00M | 153.00M | 138.00M | 126.00M | 103.00M | 52.00M | 40.00M | 68.00M |
| Depreciation & Amortization | 13.51B | 13.30B | 12.82B | 11.87B | 11.78B | 10.76B | 10.56B | 11.02B | 10.85B | 9.37B | 10.01B | 10.82B | 9.31B | 9.34B | 8.24B | 7.39B | 6.83B | 5.98B | 4.03B |
| EBITDA | 57.44B | 43.45B | 41.92B | 32.54B | 59.42B | 55.54B | 52.32B | 44.25B | 56.12B | 38.60B | 44.85B | 45.41B | 25.50B | 23.23B | 29.72B | 18.47B | 37.88B | 30.92B | 20.59B |
| EBITDA Ratio | 2.01% | 1.71% | 1.76% | 1.69% | 2.56% | 2.50% | 2.40% | 2.15% | 2.58% | 2.00% | 2.19% | 1.98% | 1.19% | 1.26% | 1.49% | 1.21% | 2.20% | 2.11% | 1.66% |
| Operating Income | 38.46B | 30.15B | 29.09B | 20.67B | 47.65B | 44.77B | 41.76B | 33.23B | 45.29B | 29.23B | 34.96B | 23.55B | 9.38B | 9.31B | 14.66B | 8.78B | 25.35B | 21.99B | 14.85B |
| Operating Income Ratio | 1.35% | 1.12% | 1.13% | 0.79% | 1.77% | 1.70% | 1.60% | 1.30% | 1.76% | 1.21% | 1.40% | 0.99% | 0.40% | 0.43% | 0.71% | 0.45% | 1.43% | 1.38% | 1.05% |
| Total Other Income/Expenses | 5.34B | 8.44B | 19.09B | 8.60B | 11.59B | 16.46B | 9.81B | 11.46B | 8.81B | 8.00B | 8.26B | 10.89B | 6.66B | 4.43B | 6.70B | 2.20B | 5.64B | 2.91B | 1.65B |
| Income Before Tax | 43.80B | 38.59B | 48.18B | 36.53B | 59.23B | 61.23B | 51.57B | 44.68B | 54.09B | 37.23B | 43.23B | 34.44B | 16.04B | 13.75B | 21.36B | 10.98B | 31.00B | 24.90B | 16.49B |
| Income Before Tax Ratio | 1.53% | 1.43% | 1.86% | 1.40% | 2.19% | 2.32% | 1.98% | 1.75% | 2.10% | 1.54% | 1.73% | 1.44% | 0.69% | 0.63% | 1.04% | 0.57% | 1.75% | 1.57% | 1.17% |
| Income Tax Expense | 14.22B | 12.80B | 15.98B | 12.04B | 18.91B | 19.49B | 15.86B | 13.60B | 18.71B | 14.31B | 17.65B | 13.45B | 9.11B | 7.06B | 10.37B | 4.90B | 14.06B | 12.10B | 9.15B |
| Net Income | 29.56B | 25.79B | 32.18B | 24.50B | 40.27B | 41.70B | 35.59B | 30.89B | 34.98B | 22.92B | 25.57B | 20.77B | 6.60B | 6.59B | 10.50B | 5.57B | 16.18B | 11.94B | 7.07B |
| Net Income Ratio | 1.03% | 0.96% | 1.24% | 0.94% | 1.49% | 1.58% | 1.37% | 1.21% | 1.36% | 0.95% | 1.02% | 0.87% | 0.28% | 0.30% | 0.51% | 0.29% | 0.91% | 0.75% | 0.50% |
| EPS | 154.13 | 127.42 | 153.57 | 115.75 | 190.26 | 195.79 | 164.25 | 142.58 | 158.99 | 102.48 | 115.51 | 97.48 | 32.24 | 32.42 | 56.80 | 33.32 | 99.12 | 75.48 | 47.39 |
| EPS Diluted | 154.13 | 127.42 | 153.57 | 115.75 | 190.26 | 195.79 | 164.25 | 142.58 | 158.99 | 102.48 | 115.51 | 97.48 | 32.24 | 32.42 | 56.80 | 33.32 | 99.12 | 75.48 | 47.39 |
| Weighted Avg Shares Out | 191.78M | 202.37M | 209.56M | 211.67M | 211.67M | 212.98M | 216.68M | 216.68M | 219.98M | 223.67M | 221.34M | 213.08M | 204.83M | 203.17M | 184.82M | 167.04M | 163.20M | 158.20M | 145.71M |
| Weighted Avg Shares Out (Dil) | 191.78M | 202.37M | 209.56M | 211.67M | 211.67M | 212.98M | 216.68M | 216.68M | 219.98M | 223.67M | 221.34M | 213.08M | 204.83M | 203.17M | 184.82M | 167.04M | 163.20M | 158.20M | 145.71M |
Source: https://incomestatements.info
Category: Stock Reports